Form 4: Mereo BioPharma General Counsel Sells Shares to Cover Tax Obligations

Charles Sermon, General Counsel of Mereo BioPharma Group plc, sold American Depositary Shares (ADS) to cover tax withholding obligations related to vested restricted stock units.

Summary

• Charles Sermon, the General Counsel of Mereo BioPharma Group plc, reported the sale of American Depositary Shares (ADS) on September 12 and 13, 2024.
• The sales were executed to cover tax withholding obligations associated with the vesting of performance-based restricted stock units under the company's 2019 Employee Incentive Plan.
• On September 12, 2024, 9,980 ADSs were sold at a weighted average price of $4.4727.
• On September 13, 2024, 20,946 ADSs were sold at a weighted average price of $4.221.
• Following these transactions, Sermon beneficially owns 219,061 ADSs and 4 ordinary shares of Mereo BioPharma Group plc.
• The sales were mandated by the Issuer's election under its Plan to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of stock sales to cover tax obligations, which is neither particularly positive nor negative. It's a neutral event in the context of insider trading regulations.

Management Comments

• These sales are mandated by the Issuer's election under its Plan to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The sale of shares by a company insider could have a minor impact on shareholder sentiment, although the stated reason (tax obligations) mitigates potential concerns.

Key Dates